GLP/3 RETA 

Research-grade incretin-pathway material prepared for consistency and clear documentation in professional lab workflows.

Scientific Information

• Compound: GLP-3 RETA
• Molecular Formula: C₂₂₁H₃₄₃N₅₁O₆₄
• Molecular Weight: 4731.42 g/mol
• CAS Number: 2381089-83-2
• Sequence / Structure: 39-residue triple incretin agonist peptide
• Classification: Triple incretin receptor agonist (GLP-1 / GIP / glucagon) research peptide

Specifications

• Compound: GLP-3 RETA

• Class: Triple receptor agonist research category (GLP-1, GIP, glucagon)

• Form and appearance: Lyophilized powder, white to off-white

• Amount: 10mg, 20mg, 30mg per vial

• Purity: ≥99%

• Storage, lyophilized: Cool, dry, away from light

• Storage: Follow approved internal laboratory SOPs.

• Key Features

  • 10mg, 20mg, 30mg GLP-3 RETA per vial (lyophilized powder)

  • ≥99% purity for reproducible results

  • Sterile, sealed glass vial with tamper-evident flip cap

  • Ancillary laboratory materials not included

What’s Included

• 1 × GLP-3 RETA your choice of 10mg, 20mg, 30mg vial (ancillary laboratory materials not included)

Compliance

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.